Drug Type Small molecule drug |
Synonyms NT-104 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Injuries, Traumatic | Phase 1 | US | NeuroTrauma Sciences LLCStartup | 06 Nov 2021 |
Ischemic stroke | Phase 1 | US | NeuroTrauma Sciences LLCStartup | 06 Nov 2021 |